Abstract
Lavandula angustifolia is a well known herbal medicinal plant with a variety of useful properties, cultivated in the hill area of Uttarakhand was found to have 0.55 % essential oil on dry weight basis analyzed by GC and GC-MS. Thirty four constituents, representing 96.41% of the oil were identified. The higher percentage of major components is linalyl acetate (39.10%), linalool (29.7%), α- terpineol (4.35%), and trans caryophyllene (3.76%). The quality of lavender oil produced in Garhwal Himalayan region can be compared with other parts of the globe which indicates its international quantity.
Keywords: Essential oil, GC-MS, lamiaceae, Lavandula angustifola, linalyl acetate.
Graphical Abstract
The Natural Products Journal
Title:GC-MS Analysis of Essential Oil from Lavandula angustifolia Cultivated in Garhwal Himalaya
Volume: 5 Issue: 4
Author(s): Pramod Singh, Harish Andola, M.S.M. Rawat, Geeta Joshi nee Pant and J.S. Jangwan
Affiliation:
Keywords: Essential oil, GC-MS, lamiaceae, Lavandula angustifola, linalyl acetate.
Abstract: Lavandula angustifolia is a well known herbal medicinal plant with a variety of useful properties, cultivated in the hill area of Uttarakhand was found to have 0.55 % essential oil on dry weight basis analyzed by GC and GC-MS. Thirty four constituents, representing 96.41% of the oil were identified. The higher percentage of major components is linalyl acetate (39.10%), linalool (29.7%), α- terpineol (4.35%), and trans caryophyllene (3.76%). The quality of lavender oil produced in Garhwal Himalayan region can be compared with other parts of the globe which indicates its international quantity.
Export Options
About this article
Cite this article as:
Singh Pramod, Andola Harish, Rawat M.S.M., nee Pant Geeta Joshi and Jangwan J.S., GC-MS Analysis of Essential Oil from Lavandula angustifolia Cultivated in Garhwal Himalaya, The Natural Products Journal 2015; 5 (4) . https://dx.doi.org/10.2174/2210315505666150908232137
DOI https://dx.doi.org/10.2174/2210315505666150908232137 |
Print ISSN 2210-3155 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-3163 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
SIST-M-IR Activities of Daily Living Items that Best Discriminate Clinically Normal Elderly from those with Mild Cognitive Impairment
Current Alzheimer Research The Implications of Autophagy in Alzheimer’s Disease
Current Alzheimer Research Commentary-1 (Research Highlights: USP30 Regulates the Mitophagy-Mediated Neuroprotection in Parkinson’s Disease)
CNS & Neurological Disorders - Drug Targets Transient Receptor Potential Vanilloid 1 and Xenobiotics
CNS & Neurological Disorders - Drug Targets Inhibition of Cytochrome P450 1A2-Mediated Metabolism and Production of Reactive Oxygen Species by Heme Oxygenase-1 in Rat Liver Microsomes
Drug Metabolism Letters Glucocorticoids, the Etiology of Obesity and the Metabolic Syndrome
Current Alzheimer Research Kratom and Future Treatment for the Opioid Addiction and Chronic Pain: Periculo Beneficium?
Current Drug Targets Editorial
Current Drug Safety A Computational Molecular Docking Studies on the Tryparedoxin Peroxidase of <i>Leishmania donovani</i> Responsible for Visceral Leishmaniasis in Human
Letters in Drug Design & Discovery The Dualistic Nature of Immune Modulation In Alzheimers Disease: Lessons from the Transgenic Models
Current Pharmaceutical Design A Developmental Psychopathology Perspective of Obsessive-Compulsive Disorder
Current Psychiatry Research and Reviews Structural Requirements of Heparin and Related Molecules to Exert a Multitude of Anti-Inflammatory Activities
Mini-Reviews in Medicinal Chemistry Targeting Ras Activity Prevented Amyloid Beta-Induced Aberrant Neuronal Cell Cycle Re-Entry and Death
Current Alzheimer Research Systemic Sclerosis: Clinical Manifestations
Current Rheumatology Reviews Patent Selections
Recent Patents on Inflammation & Allergy Drug Discovery Involvement of Heme Oxygenase-1 in Neuropsychiatric and Neurodegenerative Diseases
Current Pharmaceutical Design Recent Advances Using Phosphodiesterase 4 (PDE4) Inhibitors to Treat Inflammatory Disorders: Animal and Clinical Studies
Current Drug Therapy Intracranial Atherosclerotic Stenosis is Related to Post-stroke Cognitive Impairment: A Cross-sectional Study of Minor Stroke
Current Alzheimer Research The Indiana Alzheimer Disease Centers Symposium on Mild Cognitive Impairment. Cognitive Training in Older Adults: Lessons from the ACTIVE Study
Current Alzheimer Research Oxidative Stress and Antioxidants in Carcinogenesis and Integrative Therapy of Cancer
Current Pharmaceutical Design